| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 3.66e-05 | 27 | 48 | 3 | GO:0023026 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 1.30e-04 | 41 | 48 | 3 | GO:0023023 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 2.22e-04 | 49 | 48 | 3 | GO:0042605 | |
| GeneOntologyMolecularFunction | MHC class II receptor activity | 3.07e-04 | 11 | 48 | 2 | GO:0032395 | |
| GeneOntologyMolecularFunction | neurexin family protein binding | 6.65e-04 | 16 | 48 | 2 | GO:0042043 | |
| GeneOntologyMolecularFunction | chloride ion binding | 6.65e-04 | 16 | 48 | 2 | GO:0031404 | |
| GeneOntologyBiologicalProcess | MHC class II protein complex assembly | 6.48e-06 | 16 | 48 | 3 | GO:0002399 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC class II protein complex | 6.48e-06 | 16 | 48 | 3 | GO:0002503 | |
| GeneOntologyBiologicalProcess | MHC protein complex assembly | 1.53e-05 | 21 | 48 | 3 | GO:0002396 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC protein complex | 1.53e-05 | 21 | 48 | 3 | GO:0002501 | |
| GeneOntologyBiologicalProcess | myeloid dendritic cell antigen processing and presentation | 1.59e-05 | 3 | 48 | 2 | GO:0002469 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 1.59e-05 | 3 | 48 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 2.31e-05 | 24 | 48 | 3 | GO:0071625 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 3.17e-05 | 4 | 48 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class II | 5.59e-05 | 32 | 48 | 3 | GO:0019886 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class II | 8.00e-05 | 36 | 48 | 3 | GO:0002495 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 9.42e-05 | 38 | 48 | 3 | GO:0002504 | |
| GeneOntologyBiologicalProcess | courtship behavior | 1.11e-04 | 7 | 48 | 2 | GO:0007619 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immune response to tumor cell | 1.11e-04 | 7 | 48 | 2 | GO:0002842 | |
| GeneOntologyBiologicalProcess | brainstem development | 1.47e-04 | 8 | 48 | 2 | GO:0003360 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 1.90e-04 | 48 | 48 | 3 | GO:0002478 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 2.36e-04 | 10 | 48 | 2 | GO:0097105 | |
| GeneOntologyBiologicalProcess | sensory organ development | 2.55e-04 | 730 | 48 | 8 | GO:0007423 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 2.88e-04 | 11 | 48 | 2 | GO:0097104 | |
| GeneOntologyBiologicalProcess | amino sugar biosynthetic process | 2.88e-04 | 11 | 48 | 2 | GO:0046349 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 3.34e-04 | 58 | 48 | 3 | GO:0019884 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 4.07e-04 | 13 | 48 | 2 | GO:0097090 | |
| GeneOntologyBiologicalProcess | aggressive behavior | 4.07e-04 | 13 | 48 | 2 | GO:0002118 | |
| GeneOntologyBiologicalProcess | N-acetylneuraminate metabolic process | 4.07e-04 | 13 | 48 | 2 | GO:0006054 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 4.41e-04 | 426 | 48 | 6 | GO:0043010 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immune response to tumor cell | 4.74e-04 | 14 | 48 | 2 | GO:0002840 | |
| GeneOntologyBiologicalProcess | male mating behavior | 5.46e-04 | 15 | 48 | 2 | GO:0060179 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 5.54e-04 | 290 | 48 | 5 | GO:0050870 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 6.23e-04 | 16 | 48 | 2 | GO:0007158 | |
| GeneOntologyBiologicalProcess | regulation of T cell activation | 6.46e-04 | 458 | 48 | 6 | GO:0050863 | |
| GeneOntologyBiologicalProcess | presynapse organization | 6.56e-04 | 73 | 48 | 3 | GO:0099172 | |
| GeneOntologyBiologicalProcess | social behavior | 6.83e-04 | 74 | 48 | 3 | GO:0035176 | |
| GeneOntologyBiologicalProcess | T cell mediated immune response to tumor cell | 7.05e-04 | 17 | 48 | 2 | GO:0002424 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 7.38e-04 | 76 | 48 | 3 | GO:0048002 | |
| GeneOntologyBiologicalProcess | biological process involved in intraspecies interaction between organisms | 7.38e-04 | 76 | 48 | 3 | GO:0051703 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | ABL1 ADGRV1 NLGN4X PHF10 PCDH7 NLGN4Y HLA-DRB1 HLA-DRB3 HLA-DRB4 | 7.42e-04 | 1077 | 48 | 9 | GO:0098609 |
| GeneOntologyBiologicalProcess | cytoplasm organization | 7.92e-04 | 18 | 48 | 2 | GO:0007028 | |
| GeneOntologyBiologicalProcess | eye development | 8.25e-04 | 480 | 48 | 6 | GO:0001654 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 8.28e-04 | 317 | 48 | 5 | GO:1903039 | |
| GeneOntologyBiologicalProcess | visual system development | 8.52e-04 | 483 | 48 | 6 | GO:0150063 | |
| GeneOntologyBiologicalProcess | sensory system development | 9.28e-04 | 491 | 48 | 6 | GO:0048880 | |
| GeneOntologyBiologicalProcess | N-acetylglucosamine metabolic process | 9.81e-04 | 20 | 48 | 2 | GO:0006044 | |
| GeneOntologyBiologicalProcess | dendritic cell antigen processing and presentation | 1.08e-03 | 21 | 48 | 2 | GO:0002468 | |
| GeneOntologyBiologicalProcess | developmental growth | 1.10e-03 | 911 | 48 | 8 | GO:0048589 | |
| GeneOntologyCellularComponent | MHC class II protein complex | 7.55e-06 | 17 | 48 | 3 | GO:0042613 | |
| GeneOntologyCellularComponent | MHC protein complex | 2.85e-05 | 26 | 48 | 3 | GO:0042611 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 3.09e-05 | 4 | 48 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | autolysosome membrane | 3.09e-05 | 4 | 48 | 2 | GO:0120281 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 7.06e-05 | 35 | 48 | 3 | GO:0098553 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.83e-04 | 48 | 48 | 3 | GO:0098576 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 2.07e-04 | 237 | 48 | 5 | GO:0030136 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 3.59e-04 | 147 | 48 | 4 | GO:0030665 | |
| GeneOntologyCellularComponent | symmetric synapse | 3.96e-04 | 13 | 48 | 2 | GO:0032280 | |
| GeneOntologyCellularComponent | endosome membrane | 4.19e-04 | 602 | 48 | 7 | GO:0010008 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 4.29e-04 | 64 | 48 | 3 | GO:0012507 | |
| GeneOntologyCellularComponent | late endosome membrane | 7.54e-04 | 179 | 48 | 4 | GO:0031902 | |
| GeneOntologyCellularComponent | autolysosome | 7.72e-04 | 18 | 48 | 2 | GO:0044754 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 7.95e-04 | 79 | 48 | 3 | GO:0030669 | |
| GeneOntologyCellularComponent | glycinergic synapse | 9.55e-04 | 20 | 48 | 2 | GO:0098690 | |
| GeneOntologyCellularComponent | late endosome | 1.18e-03 | 348 | 48 | 5 | GO:0005770 | |
| GeneOntologyCellularComponent | coated vesicle | 1.37e-03 | 360 | 48 | 5 | GO:0030135 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 1.38e-03 | 24 | 48 | 2 | GO:0098985 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 1.49e-03 | 215 | 48 | 4 | GO:0030662 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 1.62e-03 | 101 | 48 | 3 | GO:0045334 | |
| GeneOntologyCellularComponent | secondary lysosome | 1.62e-03 | 26 | 48 | 2 | GO:0005767 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 2.06e-03 | 110 | 48 | 3 | GO:0030134 | |
| GeneOntologyCellularComponent | trans-Golgi network membrane | 2.17e-03 | 112 | 48 | 3 | GO:0032588 | |
| GeneOntologyCellularComponent | inhibitory synapse | 2.30e-03 | 31 | 48 | 2 | GO:0060077 | |
| GeneOntologyCellularComponent | postsynaptic density | 3.65e-03 | 451 | 48 | 5 | GO:0014069 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 4.53e-03 | 293 | 48 | 4 | GO:0030658 | |
| GeneOntologyCellularComponent | asymmetric synapse | 4.63e-03 | 477 | 48 | 5 | GO:0032279 | |
| GeneOntologyCellularComponent | endosome | OSBPL11 GGA2 ATP6AP1 ANTXR2 NEDD4L HLA-DRB1 HLA-DRB3 HLA-DRB4 | 4.73e-03 | 1167 | 48 | 8 | GO:0005768 |
| GeneOntologyCellularComponent | trans-Golgi network | 5.28e-03 | 306 | 48 | 4 | GO:0005802 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 5.61e-03 | 157 | 48 | 3 | GO:0098839 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 5.78e-03 | 503 | 48 | 5 | GO:0099572 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 6.33e-03 | 164 | 48 | 3 | GO:0098982 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 6.79e-03 | 523 | 48 | 5 | GO:0098984 | |
| Domain | MHC_II_b_N | 8.29e-07 | 8 | 47 | 3 | PD000328 | |
| Domain | MHC_II_beta | 1.24e-06 | 9 | 47 | 3 | PF00969 | |
| Domain | MHC_II_b_N | 1.24e-06 | 9 | 47 | 3 | IPR000353 | |
| Domain | MHC_II_beta | 1.24e-06 | 9 | 47 | 3 | SM00921 | |
| Domain | MHC_II_a/b_N | 5.33e-06 | 14 | 47 | 3 | IPR014745 | |
| Domain | - | 5.33e-06 | 14 | 47 | 3 | 3.10.320.10 | |
| Domain | NLGN4 | 6.20e-06 | 2 | 47 | 2 | IPR030025 | |
| Domain | Nlgn | 6.17e-05 | 5 | 47 | 2 | IPR000460 | |
| Domain | MHC_I/II-like_Ag-recog | 1.18e-04 | 38 | 47 | 3 | IPR011162 | |
| Domain | C1-set | 3.39e-04 | 54 | 47 | 3 | PF07654 | |
| Domain | IGc1 | 3.77e-04 | 56 | 47 | 3 | SM00407 | |
| Domain | Ig_C1-set | 4.18e-04 | 58 | 47 | 3 | IPR003597 | |
| Domain | Ig/MHC_CS | 4.18e-04 | 58 | 47 | 3 | IPR003006 | |
| Domain | IG_MHC | 4.62e-04 | 60 | 47 | 3 | PS00290 | |
| Domain | Carboxylesterase_B_CS | 4.75e-04 | 13 | 47 | 2 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 5.53e-04 | 14 | 47 | 2 | PS00941 | |
| Domain | COesterase | 5.53e-04 | 14 | 47 | 2 | PF00135 | |
| Domain | CarbesteraseB | 5.53e-04 | 14 | 47 | 2 | IPR002018 | |
| Domain | DUF1605 | 8.23e-04 | 17 | 47 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 8.23e-04 | 17 | 47 | 2 | PF07717 | |
| Domain | HA2 | 9.24e-04 | 18 | 47 | 2 | SM00847 | |
| Domain | HA2 | 9.24e-04 | 18 | 47 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 9.24e-04 | 18 | 47 | 2 | IPR007502 | |
| Domain | - | 3.33e-03 | 119 | 47 | 3 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 3.33e-03 | 119 | 47 | 3 | IPR029058 | |
| Domain | DEAH_ATP_HELICASE | 4.11e-03 | 38 | 47 | 2 | PS00690 | |
| Pathway | BIOCARTA_BBCELL_PATHWAY | 2.94e-06 | 11 | 38 | 3 | M22030 | |
| Pathway | BIOCARTA_EOSINOPHILS_PATHWAY | 2.94e-06 | 11 | 38 | 3 | M22048 | |
| Pathway | BIOCARTA_IL5_PATHWAY | 5.07e-06 | 13 | 38 | 3 | M18928 | |
| Pathway | BIOCARTA_MHC_PATHWAY | 6.44e-06 | 14 | 38 | 3 | M22023 | |
| Pathway | BIOCARTA_TCRA_PATHWAY | 6.44e-06 | 14 | 38 | 3 | M10765 | |
| Pathway | BIOCARTA_BLYMPHOCYTE_PATHWAY | 6.44e-06 | 14 | 38 | 3 | M1473 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION | 8.04e-06 | 15 | 38 | 3 | M47588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES | 8.04e-06 | 15 | 38 | 3 | M47604 | |
| Pathway | BIOCARTA_ASBCELL_PATHWAY | 8.04e-06 | 15 | 38 | 3 | M7298 | |
| Pathway | BIOCARTA_CSK_PATHWAY | 2.69e-05 | 22 | 38 | 3 | M6327 | |
| Pathway | BIOCARTA_CTLA4_PATHWAY | 2.69e-05 | 22 | 38 | 3 | M1467 | |
| Pathway | BIOCARTA_TH1TH2_PATHWAY | 3.08e-05 | 23 | 38 | 3 | M6705 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 3.62e-05 | 70 | 38 | 4 | M12294 | |
| Pathway | REACTOME_PD_1_SIGNALING | 5.65e-05 | 28 | 38 | 3 | M18810 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 6.29e-05 | 29 | 38 | 3 | M6910 | |
| Pathway | KEGG_ASTHMA | 6.98e-05 | 30 | 38 | 3 | M13950 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 1.32e-04 | 37 | 38 | 3 | M18615 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 1.54e-04 | 39 | 38 | 3 | M16523 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 1.79e-04 | 41 | 38 | 3 | M13519 | |
| Pathway | REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING | 1.96e-04 | 8 | 38 | 2 | M27351 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 2.07e-04 | 43 | 38 | 3 | M12617 | |
| Pathway | KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION | 2.87e-04 | 48 | 38 | 3 | M615 | |
| Pathway | REACTOME_TCR_SIGNALING | 3.34e-04 | 124 | 38 | 4 | M15381 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 3.55e-04 | 126 | 38 | 4 | M705 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 3.65e-04 | 52 | 38 | 3 | M13103 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 4.36e-04 | 133 | 38 | 4 | M16476 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 4.54e-04 | 56 | 38 | 3 | M27616 | |
| Pathway | PID_TRKR_PATHWAY | 5.84e-04 | 61 | 38 | 3 | M187 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 6.31e-04 | 14 | 38 | 2 | M47364 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK3_TRKC | 9.38e-04 | 17 | 38 | 2 | M27918 | |
| Pathway | KEGG_LEISHMANIA_INFECTION | 9.48e-04 | 72 | 38 | 3 | M3126 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 1.03e-03 | 74 | 38 | 3 | M17386 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 1.18e-03 | 19 | 38 | 2 | M22005 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.64e-03 | 87 | 38 | 3 | M27617 | |
| Pathway | KEGG_HEMATOPOIETIC_CELL_LINEAGE | 1.64e-03 | 87 | 38 | 3 | M6856 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 1.69e-03 | 88 | 38 | 3 | M16004 | |
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 20371654 | ||
| Pubmed | Association of HLA-DR3 and HLA-DR4 with sinonasal polyposis in Mexican Mestizos. | 2.47e-09 | 3 | 48 | 3 | 16815190 | |
| Pubmed | Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function. | 2.47e-09 | 3 | 48 | 3 | 8775462 | |
| Pubmed | A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL. | 2.47e-09 | 3 | 48 | 3 | 12008082 | |
| Pubmed | Allelic variation in the DR subregion of the human major histocompatibility complex. | 9.86e-09 | 4 | 48 | 3 | 3476943 | |
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 26740600 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 17002906 | ||
| Pubmed | HLA-DRB alleles and systemic lupus erythematosus in Jamaicans. | 9.86e-09 | 4 | 48 | 3 | 12144077 | |
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 18520346 | ||
| Pubmed | HLA DR B1*04, *07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis. | 9.86e-09 | 4 | 48 | 3 | 15795121 | |
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 14677183 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 19922436 | ||
| Pubmed | HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. | 2.46e-08 | 5 | 48 | 3 | 17763415 | |
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 11782380 | ||
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 17910142 | ||
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 16973583 | ||
| Pubmed | Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. | 2.46e-08 | 5 | 48 | 3 | 1970352 | |
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 7645219 | ||
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 12392858 | ||
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 15908298 | ||
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 12209103 | ||
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 23152536 | ||
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 17411376 | ||
| Pubmed | Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. | 2.46e-08 | 5 | 48 | 3 | 17507489 | |
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 7734415 | ||
| Pubmed | Visual hallucinations and HLA class II antigens in cortical dementia. | 2.46e-08 | 5 | 48 | 3 | 20606439 | |
| Pubmed | HLA-DR and DQB1 gene polymorphism in the North-western Colombian population. | 2.46e-08 | 5 | 48 | 3 | 12144632 | |
| Pubmed | HLA-DQA is associated with abdominal aortic aneurysms in the Belgian population. | 2.46e-08 | 5 | 48 | 3 | 17182961 | |
| Pubmed | HIV-1 gag polyprotein rescues HLA-DR intracellular transport in a human CD4+ cell line. | 2.46e-08 | 5 | 48 | 3 | 12202216 | |
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 18223493 | ||
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 11082517 | ||
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 15896200 | ||
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 19233472 | ||
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 17153701 | ||
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 18305173 | ||
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 15902698 | ||
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 11997714 | ||
| Pubmed | Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals. | 4.92e-08 | 6 | 48 | 3 | 3372263 | |
| Pubmed | HLA risk markers for chronic myelogenous leukemia in Eastern Canada. | 4.92e-08 | 6 | 48 | 3 | 19235017 | |
| Pubmed | HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. | 4.92e-08 | 6 | 48 | 3 | 14508706 | |
| Pubmed | 8.60e-08 | 7 | 48 | 3 | 18569076 | ||
| Pubmed | 8.60e-08 | 7 | 48 | 3 | 1905983 | ||
| Pubmed | Human macrophages accumulate HIV-1 particles in MHC II compartments. | 8.60e-08 | 7 | 48 | 3 | 12230470 | |
| Pubmed | [Human leukocyte antigen genes to genetic predisposition in diffuse panbronchiolitis]. | 8.60e-08 | 7 | 48 | 3 | 18846964 | |
| Pubmed | 8.60e-08 | 7 | 48 | 3 | 20307907 | ||
| Pubmed | 1.37e-07 | 8 | 48 | 3 | 17106278 | ||
| Pubmed | 1.37e-07 | 8 | 48 | 3 | 19223392 | ||
| Pubmed | Correlation between HLA and pityriasis rosea susceptibility in Brazilian blacks. | 1.37e-07 | 8 | 48 | 3 | 16405603 | |
| Pubmed | 1.37e-07 | 8 | 48 | 3 | 12296785 | ||
| Pubmed | 1.37e-07 | 8 | 48 | 3 | 23729440 | ||
| Pubmed | 2.06e-07 | 9 | 48 | 3 | 23170932 | ||
| Pubmed | 2.06e-07 | 9 | 48 | 3 | 24505475 | ||
| Pubmed | 2.94e-07 | 10 | 48 | 3 | 15784911 | ||
| Pubmed | 2.94e-07 | 10 | 48 | 3 | 12956878 | ||
| Pubmed | 2.94e-07 | 10 | 48 | 3 | 8450224 | ||
| Pubmed | 4.04e-07 | 11 | 48 | 3 | 21085635 | ||
| Pubmed | 4.04e-07 | 11 | 48 | 3 | 26403076 | ||
| Pubmed | 4.04e-07 | 11 | 48 | 3 | 22808111 | ||
| Pubmed | Advancing the understanding of autism disease mechanisms through genetics. | 6.99e-07 | 13 | 48 | 3 | 27050589 | |
| Pubmed | HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4. | 8.88e-07 | 14 | 48 | 3 | 7512597 | |
| Pubmed | Interaction of CD4 with HLA class II antigens and HIV gp120. | 8.88e-07 | 14 | 48 | 3 | 1869305 | |
| Pubmed | 8.88e-07 | 14 | 48 | 3 | 17431094 | ||
| Pubmed | 1.11e-06 | 15 | 48 | 3 | 8376762 | ||
| Pubmed | 1.11e-06 | 15 | 48 | 3 | 8168144 | ||
| Pubmed | Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein. | 1.11e-06 | 15 | 48 | 3 | 22860026 | |
| Pubmed | 1.11e-06 | 15 | 48 | 3 | 7602119 | ||
| Pubmed | 1.11e-06 | 15 | 48 | 3 | 1967269 | ||
| Pubmed | 1.11e-06 | 15 | 48 | 3 | 9079699 | ||
| Pubmed | 1.11e-06 | 15 | 48 | 3 | 3489470 | ||
| Pubmed | 1.11e-06 | 15 | 48 | 3 | 10729169 | ||
| Pubmed | Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. | 1.36e-06 | 16 | 48 | 3 | 2846691 | |
| Pubmed | 1.36e-06 | 16 | 48 | 3 | 1978941 | ||
| Pubmed | Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. | 1.36e-06 | 16 | 48 | 3 | 2543930 | |
| Pubmed | 1.36e-06 | 16 | 48 | 3 | 17959659 | ||
| Pubmed | Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. | 1.36e-06 | 16 | 48 | 3 | 9223324 | |
| Pubmed | 1.65e-06 | 17 | 48 | 3 | 25240755 | ||
| Pubmed | HLA-DRB1 and -DRB3 allele frequencies and haplotypic associations in Koreans. | 1.87e-06 | 2 | 48 | 2 | 15041167 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 2592019 | ||
| Pubmed | The unusual DRB1*08:01 haplotype carrying DRB3*02:02 confirmed in a Dutch family. | 1.87e-06 | 2 | 48 | 2 | 23742216 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24628273 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 22671039 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 30282837 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 3596674 | ||
| Pubmed | Mutations and selection in the generation of class II histocompatibility antigen polymorphism. | 1.87e-06 | 2 | 48 | 2 | 6589154 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 21447263 | ||
| Pubmed | HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretion. | 1.87e-06 | 2 | 48 | 2 | 21484216 | |
| Pubmed | DRB1*03 diversity and DRB3 associations in five major population groups in the United States. | 1.87e-06 | 2 | 48 | 2 | 11872240 | |
| Pubmed | Structural organization of the DR subregion of the human major histocompatibility complex. | 1.87e-06 | 2 | 48 | 2 | 3860851 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 18434543 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 2497068 | ||
| Pubmed | HLA-DR4 as a risk allele for autism acting in mothers of probands possibly during pregnancy. | 1.87e-06 | 2 | 48 | 2 | 19487610 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 20164547 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23183221 | ||
| Pubmed | [Linkage of allergic rhinitis with HLA-DRB alleles polymorphism]. | 1.87e-06 | 2 | 48 | 2 | 12541760 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24855039 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 20972469 | ||
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 1.87e-06 | 2 | 48 | 2 | 37001827 | |
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 1.87e-06 | 2 | 48 | 2 | 37080762 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 18258695 | ||
| Pubmed | Identification of a novel HLA-DRB1 allele (HLA-DRB1*111902*). | 1.87e-06 | 2 | 48 | 2 | 15982264 | |
| Cytoband | 8q24.13 | 6.59e-04 | 36 | 48 | 2 | 8q24.13 | |
| GeneFamily | C1-set domain containing | 5.01e-05 | 42 | 31 | 3 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 5.76e-05 | 44 | 31 | 3 | 588 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.95e-04 | 15 | 31 | 2 | 529 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP | 7.49e-06 | 21 | 48 | 3 | M41167 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.56e-06 | 191 | 46 | 5 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.68e-06 | 194 | 46 | 5 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-06 | 196 | 46 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 2.41e-05 | 163 | 46 | 4 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 3.25e-05 | 176 | 46 | 4 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.25e-05 | 176 | 46 | 4 | 90f8bb11f339f67f08692a0c33dd420f5cda2861 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.78e-05 | 183 | 46 | 4 | 103c4c4595d8daa677679fd2fa1e99cd398e56dd | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 3.95e-05 | 185 | 46 | 4 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 3.95e-05 | 185 | 46 | 4 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 4.20e-05 | 188 | 46 | 4 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.14e-05 | 198 | 46 | 4 | 0d9d401190792fd61434f1b82548253187d805f0 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 46 | 4 | 4a57d6ba1531ce4e263daccd5de487977e6a1fdd | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-Stem_cells-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 46 | 4 | b706526b9c3485889a31253a1ffd017ad3f3fddc | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 46 | 4 | f692b602bc989d35c9162e73dda813dbef8d5267 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D231|Adult / Lineage, Cell type, age group and donor | 3.42e-04 | 132 | 46 | 3 | 8d30b71776f5f6da55dc78e0c5cb27be460004e3 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-04 | 133 | 46 | 3 | f6e9a1301a3379847b215303a9b0c028841e2cc0 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-04 | 133 | 46 | 3 | 292ecfcadbaf15e0d34a3ab9bf511ab1065888bd | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.23e-04 | 142 | 46 | 3 | be63c48794a227ea55978524c0f5935342fc455e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 144 | 46 | 3 | f6061dd965a2b2fe6ad864f8aecc06d2e74881ce | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.06e-04 | 151 | 46 | 3 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 5.67e-04 | 157 | 46 | 3 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.77e-04 | 158 | 46 | 3 | debebc8534a80e5500051f6fd352dc201585968d | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic-Proliferating_Immune|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-04 | 160 | 46 | 3 | 7217730ae14840b935b3bf9aa49becbcbcd8a682 | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-04 | 160 | 46 | 3 | 317ef81460c1a31b51119a6309b11be6a8d4ea3e | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic-leukocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-04 | 160 | 46 | 3 | e6191240c93da34fc4431a35ef496edf323cb41e | |
| ToppCell | Brain_organoid-organoid_Velasco_nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 6.10e-04 | 161 | 46 | 3 | 2de213169fe1965ceaea545297228117c81d9909 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.21e-04 | 162 | 46 | 3 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | Basal_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.43e-04 | 164 | 46 | 3 | 85487a303194f5244956ec1ca2d1758d38117f41 | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial-lung_secretory_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.43e-04 | 164 | 46 | 3 | cdb8cd2d6b369189ea77e4946738e2816d502e03 | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.43e-04 | 164 | 46 | 3 | 5dbfcdd450f652b16d97da53b528d4584b0eabcf | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.43e-04 | 164 | 46 | 3 | f1423f4434af4af9c60c8a5b0b0abec4a7df9401 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 6.43e-04 | 164 | 46 | 3 | 92fb94492fc2b683e9d50a9db6f01d23c194b0e4 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.55e-04 | 165 | 46 | 3 | f6887c64af0f26e33316bc5587487e24d76ece2a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.66e-04 | 166 | 46 | 3 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.66e-04 | 166 | 46 | 3 | 49103b75c3e08656c5774f56fd00d7bd53eefcfb | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.66e-04 | 166 | 46 | 3 | bb8135119dc37fdbba476599a56d368f422688dc | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 6.78e-04 | 167 | 46 | 3 | c0c944eae0514dc8e00d0c2892a0792e157695ec | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 6.90e-04 | 168 | 46 | 3 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-DC1|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.02e-04 | 169 | 46 | 3 | 319511ea57bbd72c2d95e8516d093689df67a912 | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 7.02e-04 | 169 | 46 | 3 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 7.14e-04 | 170 | 46 | 3 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.14e-04 | 170 | 46 | 3 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC-DC1|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.26e-04 | 171 | 46 | 3 | 459e1ac0b89571c39db98c0f578eca8f46caa8e3 | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 7.51e-04 | 173 | 46 | 3 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 7.51e-04 | 173 | 46 | 3 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.51e-04 | 173 | 46 | 3 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.51e-04 | 173 | 46 | 3 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.64e-04 | 174 | 46 | 3 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.64e-04 | 174 | 46 | 3 | 2cd6638b361ca05ab83d09ce657194aed97873b7 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.64e-04 | 174 | 46 | 3 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.64e-04 | 174 | 46 | 3 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.76e-04 | 175 | 46 | 3 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.76e-04 | 175 | 46 | 3 | 711ace94fa9a763c6ae48171a690953f25deebe4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.76e-04 | 175 | 46 | 3 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.76e-04 | 175 | 46 | 3 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 176 | 46 | 3 | 6b4afd2c9268172063fe5832896bea15e862579e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.89e-04 | 176 | 46 | 3 | 75412d58438d71c49a6096bb2ef12b7f349653d8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.89e-04 | 176 | 46 | 3 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.02e-04 | 177 | 46 | 3 | a235ff4f37a7622216526191efc4832fb8ed6957 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.02e-04 | 177 | 46 | 3 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | wk_15-18-Epithelial-PNS-COL20A1+_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.02e-04 | 177 | 46 | 3 | b8cc6a7abf83a9844a5293b6cc4b19135b51fd53 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.16e-04 | 178 | 46 | 3 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.16e-04 | 178 | 46 | 3 | 38ffbd01230c99f52274424ee6c172381daffc73 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ|normal_Lymph_Node / Location, Cell class and cell subclass | 8.16e-04 | 178 | 46 | 3 | d75057e7463558a0d3cebde3c30befbf4704dd9a | |
| ToppCell | wk_08-11-Epithelial-PNS-Proliferating_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.29e-04 | 179 | 46 | 3 | ab23fee9adab1e63d5b5cd9faba6b9a92beef425 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 8.29e-04 | 179 | 46 | 3 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.29e-04 | 179 | 46 | 3 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.29e-04 | 179 | 46 | 3 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.29e-04 | 179 | 46 | 3 | 27ad6a609fe1f7532b142d0147bccf918704a6dd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.42e-04 | 180 | 46 | 3 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 8.42e-04 | 180 | 46 | 3 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 8.42e-04 | 180 | 46 | 3 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.42e-04 | 180 | 46 | 3 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.42e-04 | 180 | 46 | 3 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.56e-04 | 181 | 46 | 3 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.56e-04 | 181 | 46 | 3 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 8.56e-04 | 181 | 46 | 3 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | Control-Myeloid-Alveolar_macrophages|Control / group, cell type (main and fine annotations) | 8.56e-04 | 181 | 46 | 3 | 8d2102c8c86c59a82610f26f90946b290552e666 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-aDC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.56e-04 | 181 | 46 | 3 | 8f7e5c310f4cdc4b2fb54fea950d01e56bd298e1 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 8.56e-04 | 181 | 46 | 3 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.70e-04 | 182 | 46 | 3 | 728a2152c166551ac229370c0900fe2bc426ea9b | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.70e-04 | 182 | 46 | 3 | f7f9be9c7ef8da9864d6aefe20043b26e1bb8697 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.70e-04 | 182 | 46 | 3 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-04 | 182 | 46 | 3 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 8.84e-04 | 183 | 46 | 3 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.84e-04 | 183 | 46 | 3 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-04 | 183 | 46 | 3 | 19e7be1cfdd111bfb840532a6f7c780345dffccf | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 8.84e-04 | 183 | 46 | 3 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.84e-04 | 183 | 46 | 3 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.84e-04 | 183 | 46 | 3 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-04 | 183 | 46 | 3 | b153425ab0df1e5fa9b953e1f6d4e8e3dc6621b0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.84e-04 | 183 | 46 | 3 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 8.84e-04 | 183 | 46 | 3 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.84e-04 | 183 | 46 | 3 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 8.84e-04 | 183 | 46 | 3 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 8.84e-04 | 183 | 46 | 3 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 8.98e-04 | 184 | 46 | 3 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.98e-04 | 184 | 46 | 3 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.98e-04 | 184 | 46 | 3 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.98e-04 | 184 | 46 | 3 | d48807f9da48bdd015a54c606d2e2a311f181396 | |
| Disease | autistic disorder (is_implicated_in) | 5.54e-07 | 42 | 46 | 4 | DOID:12849 (is_implicated_in) | |
| Disease | aspirin-induced respiratory disease (is_implicated_in) | 5.80e-07 | 11 | 46 | 3 | DOID:0080822 (is_implicated_in) | |
| Disease | brain connectivity measurement | 3.54e-05 | 400 | 46 | 6 | EFO_0005210 | |
| Disease | extranodal nasal NK/T cell lymphoma | 3.55e-05 | 6 | 46 | 2 | MONDO_0019472 | |
| Disease | Autism spectrum disorder | 4.97e-05 | 7 | 46 | 2 | cv:C1510586 | |
| Disease | Syndactyly | 6.62e-05 | 8 | 46 | 2 | C0039075 | |
| Disease | Paranoia | 1.30e-04 | 11 | 46 | 2 | C1456784 | |
| Disease | susceptibility to hepatitis B infection measurement | 1.38e-04 | 64 | 46 | 3 | EFO_0008405 | |
| Disease | esophageal squamous cell carcinoma | 1.83e-04 | 13 | 46 | 2 | EFO_0005922 | |
| Disease | small cell lung carcinoma | 2.68e-04 | 80 | 46 | 3 | EFO_0000702 | |
| Disease | pemphigus vulgaris | 2.81e-04 | 16 | 46 | 2 | EFO_0004719 | |
| Disease | hepatitis B virus infection | 4.00e-04 | 19 | 46 | 2 | EFO_0004197 | |
| Disease | Lymphoma, Follicular | 4.44e-04 | 20 | 46 | 2 | C0024301 | |
| Disease | LEOPARD Syndrome | 5.38e-04 | 22 | 46 | 2 | C0175704 | |
| Disease | Autistic Disorder | 7.29e-04 | 261 | 46 | 4 | C0004352 | |
| Disease | glycoprotein measurement | 8.55e-04 | 119 | 46 | 3 | EFO_0004555 | |
| Disease | response to vaccine | 9.19e-04 | 122 | 46 | 3 | EFO_0004645 | |
| Disease | longevity, healthspan, parental longevity | 9.40e-04 | 29 | 46 | 2 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | respiratory failure, COVID-19 | 9.40e-04 | 29 | 46 | 2 | EFO_0009686, MONDO_0100096 | |
| Disease | pursuit maintenance gain measurement | 9.41e-04 | 123 | 46 | 3 | EFO_0008433 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVHKVKNIPSIFNTP | 796 | Q8WY36 | |
| PSVVQVTIKPNDKPY | 376 | Q8WXG9 | |
| THQPPQTKWYTPIKG | 436 | P58335 | |
| QATISPPLQPKTKTY | 196 | Q7Z478 | |
| IPPVQTLSYSKPLHN | 301 | Q2KHR3 | |
| TPTKAYQLHSRPVPK | 661 | Q9NS87 | |
| PKNHNYLQPTKPVVS | 46 | Q96Q35 | |
| TNKINKDHIPVPYQP | 501 | Q6VAB6 | |
| TSPKSYPSQKHAPVL | 311 | P40123 | |
| YKSSSPLPTVQLHPQ | 996 | O60245 | |
| KNGIVPLKSSPVPHY | 211 | Q8TBE9 | |
| KIIQKTPYPHPRGTT | 36 | A8MQ11 | |
| LNYVSQKSVPKEVPP | 431 | Q9UJY4 | |
| KQHRTAPYPPQNISV | 216 | Q16827 | |
| HVIQVPQGKYKVLPT | 231 | Q8WUB8 | |
| PNQPVPQDTKFIHTK | 536 | Q8NFZ3 | |
| TKLPNPHYTPEISTK | 3326 | Q9P2D7 | |
| PQVTVYPAKTQPLQH | 126 | P79483 | |
| SKPVKVIYINSPLPQ | 316 | Q659A1 | |
| PYKIPNTELIHQSSP | 976 | Q8TF46 | |
| PTPAQKTPAKVVYVF | 166 | O00512 | |
| PKVTVYPSKTQPLQH | 126 | P01911 | |
| TTLHYPAPKRNKPTV | 211 | P00519 | |
| PTDQKVYQSKPATLP | 36 | Q9BSJ5 | |
| PKVTVYPSKTQPLQH | 126 | P13762 | |
| PAVALPPTHKKQYQQ | 531 | Q8WUF5 | |
| PNQPVPQDTKFIHTK | 536 | Q8N0W4 | |
| VYHKPLWKIIPTTQP | 731 | Q9BXB4 | |
| IYKPHPQDPEKTVLT | 111 | Q9Y3B1 | |
| PKQRKQSVYTPPTIK | 66 | Q8WVI7 | |
| NQTVEKPNVKPPASY | 216 | Q8NHU6 | |
| QSTSQHIPKLPPKTY | 1296 | Q07889 | |
| KAPDKPIQVVYVPSH | 226 | Q15120 | |
| QPISNKPFTTKPVHL | 1771 | Q9UPX8 | |
| YLPKFKSPSVAVVQP | 656 | O75746 | |
| HPVSQKISKIQPSVP | 411 | Q15468 | |
| LNSVIKPTQYKPVPD | 161 | P28289 | |
| PVPTYPQRKTDQKGH | 36 | Q9BY07 | |
| QKQPVSPVIHPPVSY | 246 | Q15904 | |
| STYQNIQPKKPEGTP | 1126 | Q6AHZ1 | |
| PKVPVPLNTTKYNSA | 256 | Q9Y6X8 | |
| ASVLSQPQYKKIPPA | 1006 | Q9H6S0 | |
| VKLSAPVTYTKHIQP | 141 | Q9Y6M0 | |
| KTQILHIQPVKSYAP | 416 | Q53H54 | |
| PAKDIQTNVYIKHPV | 216 | P48556 | |
| HQSTPPQQKPLTLAY | 1586 | Q9C0I4 | |
| HYQKVPLKEPVPAIT | 331 | Q6ZSZ6 | |
| VTSPPEVYHKVVPQI | 111 | Q9Y303 | |
| QPSPYNSPKPQHKVT | 481 | Q96PU5 | |
| NSPKPQHKVTQSFLP | 486 | Q96PU5 |